"The increasing number of drugs that are released annually to the market and their progressive use in people who have multiple morbidities, which is promoted by clinical practice guidelines to achieve control goals based on demonstrated health results,
Extreme polypharmacy: The need to mint a new term
Audifarma |
| Tiempo de lectura: Min
- Tema: Farmacoepidemiología
- Autores: Jorge E Machado-Alba, Manuel E Machado-Duque, Andrés Gaviria-Mendoza
- Idiomas: Inglés
- Palabras clave: N/A
Machado-Alba JE, Machado-Duque ME, Gaviria-Mendoza A. Extreme polypharmacy: The need to mint a new term. Pharmacoepidemiol Drug Saf. 2020;29(2):224-225. doi:10.1002/pds.4942 Enlace: https://pubmed.ncbi.nlm.nih.gov/32004396/
